Properties & Development Archives - MassBio

Alexandria Real Estate Equities, Inc.

wpengine — Mon, 04 Dec 2023 13:31:58 +0000

Alexandria Real Estate Equities, Inc. (NYSE:ARE) is the largest and leading urban office REIT uniquely focused on collaborative science and technology campuses in AAA innovation cluster locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle Park. Alexandria has a longstanding and proven track record of developing Class A assets clustered in urban science and technology campuses that provide its innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. For additional information on Alexandria, please visit www.are.com.

The post Alexandria Real Estate Equities, Inc. appeared first on MassBio.

Berkeley Investments

wpengine — Tue, 02 Jan 2024 16:02:08 +0000

Berkeley is a Boston-based, certified minority-owned real estate investment and development company founded by Young K. Park in 1991. Since then, we have acquired and/or developed in excess of 18 million square feet of life science, cGMP, industrial, commercial office, flex, mixed-use and multi-family assets. We are nimble and full-service, leading projects from acquisition through construction. At every step, we bring a focus on innovative design and a commitment to creating dynamic properties and communities. Berkeley has a strong co-investment history of transactions with multiple financial partners including domestic and international institutions and high net worth family offices. Our experience and expertise have helped us build a track record of success across multiple, regions, property types and economic cycles.

The post Berkeley Investments appeared first on MassBio.

Biomed Realty Inc.

wpengine — Thu, 21 Dec 2023 01:31:36 +0000

BioMed Realty Trust, Inc. is a fully integrated, self-administered and self-managed real estate investment trust (REIT) that commenced operations following its initial public offering in August 2004.

BioMed Realty is an entrepreneurial company focused on Providing Real Estate to the Life Science Industry®. With over $5.0 billion invested in state-of-the-art research facilities, we have assembled a world-class portfolio of life science buildings concentrated in the seven core U.S. life science markets of Boston, San Francisco, San Diego, Maryland, New York/New Jersey, Pennsylvania and Seattle.

We currently own or have interests in properties comprising approximately 13.1 million rentable square feet.

BioMed Realty’s best-in-class group of professionals bring the unique skills and specialized expertise in life science and biotech real estate, finance, development, construction, property management and law. Our real estate team has the ability to identify properties in locations that provide life science organizations with access to the partners, people and resources that they need to grow. Our development professionals have the deep technical expertise to enhance these properties, translating life science user requirements into the appropriate physical infrastructure, including chemistry, biology and specialty use laboratory environments. BioMed Realty property management team possesses the wide-ranging skills required to operate and manage our facilities to provide the best research and working environments for our tenants.

The post Biomed Realty Inc. appeared first on MassBio.

Boston Properties

wpengine — Tue, 02 Jan 2024 16:02:09 +0000

Boston Properties, Inc. is the largest publicly-held developer and owner of Class A office properties in the United States, concentrated in five markets – Boston, Los Angeles, New York, San Francisco and Washington, DC. The Company is a fully integrated real estate company, organized as a real estate investment trust (REIT), that develops, manages, operates, acquires and owns a diverse portfolio of primarily Class A office space.

The post Boston Properties appeared first on MassBio.

Breakthrough Properties

wpengine — Fri, 15 Sep 2023 09:01:32 +0000

Breakthrough Properties is a life science real estate development company that leverages cross-sector collaboration to deliver environments that foster innovation and scientific breakthroughs.

We have combined Tishman-Speyer’s decades of global real estate development experience with Bellco Capital’s industry-making biotechnology entrepreneurship to reimagine environments where companies can create life-changing therapies for patients. At Breakthrough, we seek to be a home for scientific discovery and innovation because we understand what you do, how you do it and why you do it.

The post Breakthrough Properties appeared first on MassBio.

Capital Hall Partners

wpengine — Tue, 14 Nov 2023 15:31:10 +0000

The post Capital Hall Partners appeared first on MassBio.

Cummings Properties, LLC

wpengine — Sun, 17 Dec 2023 01:32:04 +0000

Cummings Properties operates 11 million square feet of first-class office, lab and general commercial space in 10 metropolitan Boston communities. More than 100 life-science firms occupy more than 2 million square feet of space in its buildings. Cummings Properties features a wide array of lab spaces ranging from incubator labs to cleanrooms and animal facilities. It has the in-house ability and expertise to design, build and finance all types of buildouts. A leader in Boston commercial real estate for 50 years, with an experienced team of professionals, Cummings Properties provides quality building management including leasing, space planning, design, construction and maintenance. Many of our facilities are located in MassBio rated Platinum BioReady Communities.

The post Cummings Properties, LLC appeared first on MassBio.

DivcoWest

wpengine — Tue, 28 Nov 2023 13:32:36 +0000

Founded in 1993, DivcoWest is a vertically integrated, real estate investment firm headquartered in San Francisco, with offices in Los Angeles, Menlo Park, Boston, Washington DC and New York City. Known for long-standing relationships and experience across the risk-spectrum in markets where innovation thrives, DivcoWest combines entrepreneurial spirit with an institutional approach to deliver real estate solutions and opportunities to the world’s most forward-thinking companies and investors. DivcoWest aims to create environments that inspire ingenuity, promote growth, and enhance health and well-being. Since inception, DivcoWest and its predecessor have acquired approximately 48 million square feet of commercial space – primarily throughout the United States. DivcoWest’s real estate portfolio currently includes existing and development properties in the office, R&D, lab, industrial, retail and multifamily spaces. www.divcowest.com

DivcoWest is the owner and developer of Cambridge Crossing (CX), a 43-acre transit-oriented mixed-use urban development in East Cambridge, Massachusetts with over 2 million square feet of science and technology space for growing biotech and innovation tenants. As an extension of Kendall Square, CX is ideally positioned for today’s forward-thinking tenants providing access to two MBTA stations (Green line on site and orange line minutes away), an adjacent highway, bike and foot paths, and an international airport plus is central to a high concentration of knowledge workers and like-minded tenants and business partners in East Cambridge. www.cambridgecrossing.com

The post DivcoWest appeared first on MassBio.

DLJ Real Estate Capital Partners

wpengine — Mon, 11 Dec 2023 16:02:03 +0000

The post DLJ Real Estate Capital Partners appeared first on MassBio.

Greystar

wpengine — Mon, 11 Sep 2023 15:31:05 +0000

Greystar is a leading, fully integrated real estate company offering expertise in investment management, development, and management of properties globally. Headquartered in Charleston, South Carolina, Greystar manages and operates over an estimated $220 billion of real estate in more than 200 markets globally including offices throughout the United States, United Kingdom, Europe, South America, and the Asia-Pacific region. Greystar has a robust institutional investment platform with approximately $41.3 billion of assets under management, including over $19.2 billion of assets under development.

Greystar is developing 74M, a purpose-built lab development in the emerging submarket of Somerville, Massachusetts. 74M will feature 465,000 square feet of Class-A lab, office, and R&D space. Tenants will benefit from best-in-class amenities, including a rooftop amenity lounge with an expansive outdoor terrace, conference and function rooms, a health and wellness center, ground floor retail, dedicated bike storage, and unobstructed views of the Boston and Cambridge skyline and the Mystic River. The building is on track to be LEED Platinum and WELL certified with additional WiredScore and SmartScore certifications.

The post Greystar appeared first on MassBio.